Furthermore, elevated SHROOM4 expression is associated with favorable overall survival (OS), disease-free survival (FPS), and progression-free survival (PPS) in lung cancer, exhibiting high diagnostic accuracy, especially in LUSC. Here, SHROOM4 is linked to lung carcinoma.